Spero Therapeutics’ oral antibiotic tebipenem shows Phase 3 success and supports GSK’s NDA resubmission. Click here to read my latest analysis of SPRO stock.

The United States is facing an increase in human infections by drug-resistant bacteria. One such bacteria, called New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales, is ...

Difficult-to-treat infections caused by dangerous, drug-resistant bacteria are on an alarming upward climb, the Centers for Disease Control and Prevention warned in a recent health alert. Known ...

A new study from the CDC found that infection rates for a drug-resistant “nightmare bacteria” are on the rise, increasing nearly 70% between 2019 and 2023. The increase was primarily driven by the NDM ...

CORRECTED September 30, 2025 // An earlier version of this article incorrectly stated the two drugs which are effective against NDM-CRE. The article has been updated to state aztreonam-avibactam and ...

Share on Pinterest The CDC issued a warning over a multi-drug-resistant “nightmare bacteria” that’s been surging in the United States. Getty Images A new CDC report found a sharp increase in ...

The infection rate of one type of carbapenem-resistant Enterobacterales bacteria has risen by more than 460 percent in recent years. Scientists say people receiving treatment in hospitals are at ...

Infection rates from drug-resistant "nightmare bacteria" rose almost 70% between 2019 and 2023, according to a new report from Centers for Disease Control and Prevention scientists. Bacteria that are ...

Carbapenemase-producing Enterobacterales (CRE) surge in the U.S., with New Delhi metallo-β-lactamase (NDM) becoming a major public health threat. Dangerous bacteria called carbapenemase-producing ...

The research team led by Professor Qu investigated the intrahost evolution of carbapenem-resistant Klebsiella pneumoniae (CRKP) ST11 by collecting a series of K. pneumoniae strains isolated from a ...

An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase-phenotype Gram ...